David Kirn
Chief Executive Officer at 4D Molecular Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: 4D Molecular Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
4D Molecular Therapeutics Inc. May 21, 202482.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 5, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −58,061 | $12.92 | $750,235 |
| Oct 5, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −272 | $13.61 | $3,702 |
| Sep 14, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −58,333 | $13.90 | $810,829 |
| Aug 19, 2026 | 4D Molecular Therapeutics Inc. | Option exercise | +50,000 | $4.14 | $207,000 |
| Aug 19, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −43,149 | $15.36 | $662,769 |
| Aug 19, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −25,927 | $16.42 | $425,721 |
| Aug 4, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −26,842 | $10.23 | $274,594 |
| Aug 3, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −12,415 | $10.05 | $124,771 |
| Jul 10, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −15,283 | $12.01 | $183,549 |
| Jul 10, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −442 | $12.84 | $5,675 |
| Jul 9, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −42,608 | $12.87 | $548,365 |
| Jun 22, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −114,746 | $10.47 | $1,201,391 |
| Jun 1, 2026 | 4D Molecular Therapeutics Inc. | Open-market sale | −1,922 | $10.02 | $19,258 |
| Jul 10, 2024 | 4D Molecular Therapeutics Inc. | Option exercise | +11,653 | $14.42 | $168,036 |
| Jul 10, 2024 | 4D Molecular Therapeutics Inc. | Option exercise | +1,270 | $15.78 | $20,041 |
Questions about David Kirn
What boards is David Kirn on?
David Kirn sits on the board of 4D Molecular Therapeutics Inc.
What company is David Kirn the CEO of?
David Kirn is Chief Executive Officer of 4D Molecular Therapeutics Inc.
How long has David Kirn served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.